Traws Pharma, Inc. (TRAW) Q4 2025 Earnings
Traws Pharma, Inc. reported Q4 2025 revenue of $57.0K (+0.0% YoY), missed analyst consensus of $60.0K by $3.0K. Diluted EPS came in at $-0.82, beat the $-1.22 consensus by $0.40.
Financial Snapshot
Trailing eight quarters through Q4 2025 — latest period from 8-K press release; updates when 10-Q/10-K is filed
Q4 2025 Earnings FAQ
Common questions about Traws Pharma, Inc.'s Q4 2025 earnings report.
Traws Pharma, Inc. (TRAW) reported Q4 2025 earnings on April 15, 2026 before market open.
Traws Pharma, Inc. reported revenue of $57.0K and diluted EPS of $-0.82 for Q4 2025.
Revenue missed the consensus estimate of $60.0K by $3.0K. EPS beat the consensus estimate of $-1.22 by $0.40.
Compared to the same quarter a year prior, revenue grew 0.0% from $57.0K a year earlier.
You can read the 8-K earnings release (0001104659-26-043497) directly on SEC EDGAR. The filing index links above go to sec.gov.